Harrow Health, Inc. is > 10% Shareholder of Eton Pharmaceuticals, Inc.. Currently has a direct ownership of 1.98 Million shares of ETON, which is worth approximately $33 Million. The most recent transaction as insider was on Apr 12, 2021, when has been sold 1,518,000 shares (Common Stock) at a price of $7.0 per share, resulting in proceeds of $10,626,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.98M
0% 3M change
0% 12M change
Total Value Held $33 Million

HARROW HEALTH, INC. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 12 2021
SELL
Open market or private sale
$10,626,000 $7.0 p/Share
1,518,000 Reduced 43.37%
1,982,000 Common Stock
HHI

Harrow Health, Inc.

> 10% Shareholder
Nashville, TN

Track Institutional and Insider Activities on ETON

Follow Eton Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ETON shares.

Notify only if

Insider Trading

Get notified when an Eton Pharmaceuticals, Inc. insider buys or sells ETON shares.

Notify only if

News

Receive news related to Eton Pharmaceuticals, Inc.

Track Activities on ETON